IAS 38 Intangible Assets: Recognition Criteria and the Internally Generated Problem

IAS 38 Intangible Assets: Recognition Criteria and the Internally Generated Problem

By Sai Manikanta Pedamallu (ACCA, CMA US, CSCA US, CGMA, ACMA, Dip IFRS, M.Com, MBA, MA)

Lead Instructor, Global Fin X | www.globalfinx.in/manikanta

---

IAS 38 has an uncomfortable truth at its centre: the standard was designed for an industrial economy, and most modern companies create value primarily through assets that IAS 38 forces off the balance sheet. The Infosys brand, TCS's client relationships, HDFC Bank's customer franchise, Asian Paints' distribution network. None of these appear as assets. All were built through expenditures that were expensed as incurred.

This is not an oversight. It is a deliberate position: the IASB concluded that internally generated intangibles fail one or more recognition criteria often enough that a general prohibition produces more reliable financial statements than selective recognition. The consequence is a growing gap between book value and market value for intangible-intensive companies, which I think is worth being honest about rather than glossing over.

This post covers the definition, the three recognition criteria, how different modes of acquisition affect recognition, the specific prohibitions on internally generated intangibles, subsequent measurement, and the Indian context where the tension between economic reality and accounting rules is most visible.

---

The Definition: Three Elements

An intangible asset is an identifiable, non-monetary asset without physical substance.

Three elements: identifiable, non-monetary, without physical substance. All three must be present.

Non-monetary: The asset is not cash, nor a right to receive a fixed or determinable amount of cash. A patent is non-monetary. A trade receivable is not an intangible asset; it is a financial instrument.

Without physical substance: The asset cannot be touched. Software code is intangible even when stored on a physical server. The server is tangible PPE; the code is an intangible asset. Where an intangible element is inseparable from its physical carrier (a CD-ROM containing proprietary software), judgment determines which element is more significant.

Identifiable: This is the most important element and the hardest to satisfy for internally generated items. An intangible asset is identifiable if it meets either condition:

It is separable: capable of being separated from the entity and sold, transferred, licensed, rented, or exchanged, either individually or together with a related contract, asset, or liability. The separability does not need to be intended; the capability is sufficient.

It arises from contractual or other legal rights: regardless of whether those rights are transferable or separable from the entity. A trademark registered under the Trade Marks Act is identifiable through legal rights even if the entity has no intention of selling it.

The identifiability requirement is what distinguishes intangible assets from goodwill. Goodwill represents future economic benefits from assets that cannot be individually identified and separately recognised. It is not identifiable and therefore is not an intangible asset under IAS 38.

---

The Three Recognition Criteria

An intangible asset is recognised in the financial statements only when all three criteria are satisfied simultaneously:

Criterion 1: Meets the definition (identifiable, non-monetary, without physical substance).

Criterion 2: Probable future economic benefits. Future economic benefits include revenue from sales of products or services, cost savings, and other benefits arising from the use of the asset. For separately acquired intangibles, IAS 38 presumes this criterion is always satisfied: the transaction price itself reflects the market's assessment of probable future benefits.

Criterion 3: Cost can be measured reliably. For separately acquired intangibles, cost is typically the purchase price plus directly attributable preparation costs. Reliable measurement is straightforward. For internally generated intangibles, this is where the standard becomes demanding.

The Control Problem

Between identifiability and measurement, control sits as an implicit gatekeeping condition. An entity controls an asset if it has the power to obtain future economic benefits from the asset and can restrict others' access to those benefits.

Control usually derives from legal rights. A patent gives the holder the legal right to prevent others from using the patented invention. A registered trademark gives the holder the right to prevent others from using the mark. These legal rights establish control.

Without legal protection, control is harder to establish. A company that has trained its engineers in a proprietary methodology does not control the future economic benefits from that training. The engineers can resign, taking the knowledge with them. The training expenditure fails the control test. Expensed.

Customer relationships maintained through goodwill and service quality, without any contractual lock-in, also fail the control test. The customers are free to leave. Expensed.

---

How Acquisition Mode Affects Recognition

The mode through which an intangible asset is acquired fundamentally affects whether and how it is recognised.

Separate Acquisition

A separately acquired intangible asset almost always qualifies for recognition. The probability of future economic benefits is presumed satisfied (a rational buyer would not pay unless they expected benefits). Reliable cost measurement is straightforward (the purchase price). Identifiability is assessed against the definition.

Indian example: Sun Pharmaceutical acquiring a drug licence from a smaller biotech for Rs. 200 crore. The licence is identifiable (arises from contractual rights, is separable and transferable), future benefits are probable (the market transaction evidences this), and cost is measurable reliably (Rs. 200 crore). Recognised as an intangible asset at Rs. 200 crore.

Acquisition as Part of a Business Combination

When an entity acquires a business under IFRS 3, all identifiable assets are recognised at fair value at the acquisition date. This includes intangible assets that the acquiree itself may never have recognised, because it generated them internally.

IFRS 3 uses a different recognition gateway than IAS 38: it drops the probability and reliable measurement criteria as gatekeeping conditions and relies instead on identifiability. If an intangible asset can be identified separately from goodwill, it is recognised in the purchase price allocation at fair value.

This creates a striking asymmetry: a company that builds its own customer relationships recognises nothing. When a competitor acquires that company, the acquirer recognises those customer relationships as an intangible asset at fair value. The same economic asset goes from being off-balance sheet to on-balance sheet purely by changing hands.

For India's Big 4 audit practice and corporate transactions, this asymmetry is operationally significant. Purchase price allocations under IFRS 3 for acquisitions of Indian IT companies, pharmaceutical companies, and consumer brands routinely identify customer relationships, technology assets, and trade names that target companies themselves never carried as assets.

Government Grants

An intangible asset acquired free of charge, or for nominal consideration, through a government grant may be recognised initially at either its fair value or a nominal amount plus any expenditure directly attributable to preparing it for use.

A pharmaceutical company receiving a compulsory licence from the government to produce a patented drug at nominal cost, or an IT company receiving an exploration licence for data, would apply this approach.

Internally Generated Intangible Assets: The Problem

This is where IAS 38 is most demanding and most controversial.

Generating an intangible asset internally involves two problems. First, identifying whether and when there is an identifiable asset that will generate future economic benefits. Second, determining the cost of the asset reliably. For many internally generated intangibles, neither problem can be solved reliably enough to justify balance sheet recognition.

IAS 38 breaks the generation of an internally generated intangible into two phases.

---

Research vs Development: The Critical Distinction

For internally generated intangibles, IAS 38 draws a bright line between the research phase and the development phase. This line determines whether expenditure is capitalised or expensed.

Research Phase: Always Expensed

Research is original and planned investigation undertaken to gain new scientific or technical knowledge. At the research phase, an entity cannot demonstrate that a future asset will generate probable future economic benefits. The outcome is too uncertain.

All research expenditure is expensed as incurred. No exceptions. Even if subsequent events prove that the research eventually led to a commercially successful product, the earlier research costs cannot be retroactively capitalised. Once expensed, they stay expensed.

Examples of research activities:

Activities aimed at obtaining new knowledge. Search for applications of research findings. Search for product or process alternatives. Formulation and design of possible new products.

Development Phase: Capitalise When Six Criteria Are Met

Development is the application of research findings to a plan or design for the production of new or substantially improved products or processes. By the development phase, technical feasibility may be demonstrable, and the probability of future benefits becomes assessable.

Development expenditure is capitalised as an intangible asset only when the entity can demonstrate all six of the following:

1. Technical feasibility of completing the intangible asset so it will be available for use or sale.

2. Intention to complete the asset and use or sell it.

3. Ability to use or sell the asset.

4. How the asset will generate probable future economic benefits. Existence of a market for the output, or internal usefulness if used internally.

5. Availability of adequate technical, financial, and other resources to complete the development and to use or sell the asset.

6. Ability to reliably measure the expenditure attributable to the asset during development.

All six must be demonstrated simultaneously. If any one is absent, the expenditure for that period is expensed.

The switch from expensing (research) to capitalising (development) is prospective. Once all six criteria are met, subsequent development expenditure is capitalised. Past research expenditure is never brought back onto the balance sheet.

An Indian Pharmaceutical Example

Dr. Reddy's Laboratories is developing a new generic formulation. The timeline is typical:

Phase 1: Identifying candidate molecules, running lab tests. Research phase: all expensed.

Phase 2: Lead molecule identified, bioequivalence studies commenced, regulatory submission planned. If Dr. Reddy's can now demonstrate technical feasibility (the molecule is biologically equivalent), intention and ability to complete (regulatory filing ready), a market (the generic will be sold to US pharmacy chains under an ANDA), resources (the formulation plant has capacity), and can track expenditure reliably: development phase begins. Subsequent expenditure from this point is capitalised.

Phase 3: ANDA approved, commercial launch. The capitalised development asset is amortised over its estimated commercial life.

The research-to-development switchover is a judgment call that requires documentation. An entity that capitalises too early (before all six criteria are demonstrably met) overstates assets and understates expenses. An entity that continues to expense when criteria are clearly met understates assets and overstates expenses. Auditors test the switchover timing carefully, particularly for pharmaceutical, biotech, and technology companies.

---

The Specific Prohibitions: What Can Never Be Capitalised

IAS 38 explicitly prohibits the recognition of internally generated versions of certain assets, regardless of how much was spent creating them:

Internally generated goodwill. By definition unidentifiable. Expensed.

Internally generated brands, mastheads, publishing titles, customer lists, and similar items. The expenditure cannot be distinguished from the cost of developing the business as a whole. The brand-building spend of Asian Paints, the Tata group, or Reliance Industries has generated enormous economic value. None of it appears on their balance sheets as an intangible asset.

Start-up costs. Costs of establishing a new business or opening a new facility. Expensed.

Training costs. The entity does not control the future economic benefits from trained employees. Expensed.

Advertising and promotional costs. Expensed as incurred, including direct response advertising (mail campaigns, online advertising with trackable conversion). Even if the entity can prove the advertising generates measurable future sales, the cost is expensed.

Relocation and reorganisation costs. Expensed.

These prohibitions explain why an advertising-intensive consumer goods company's most valuable assets, its brands, sit entirely off its IFRS balance sheet. The same brands, if acquired in a business combination, would appear at fair value on the acquirer's balance sheet. The recognition gap is real, persistent, and a genuine limitation of IAS 38 in a modern economy.

---

Subsequent Measurement: Cost Model and the Rare Revaluation Model

After initial recognition, an intangible asset is measured using either the cost model or the revaluation model. The choice is an accounting policy applied by class of asset.

Cost Model

Carrying amount = Cost – Accumulated amortisation – Accumulated impairment losses.

This is the default and by far the most common approach for intangible assets.

Revaluation Model

Carrying amount = Fair value at revaluation date – Subsequent accumulated amortisation – Subsequent accumulated impairment losses.

The revaluation model is available for intangible assets, but only when an active market exists for the asset. Active markets for intangible assets are rare. Commodity licences and emission rights in some jurisdictions have active markets. Most intangible assets (patents, trademarks, software, customer relationships) do not trade in active markets, making the revaluation model effectively unavailable for most intangibles in practice.

Finite vs Indefinite Useful Life

The useful life assessment drives the subsequent measurement significantly.

Finite useful life: The asset is amortised over its useful life using a method that reflects the pattern of economic benefit consumption. Straight-line is the default. Revenue-based amortisation is prohibited (same prohibition as IAS 16). The amortisation period and method are reviewed at each annual reporting date.

Residual value is assumed zero unless an active market exists for the asset at the end of its useful life (rare) or a third party has committed to purchase the asset at the end of its life.

Indefinite useful life: There is no foreseeable limit to the period over which the asset is expected to generate net cash inflows. The asset is not amortised but is tested for impairment annually (and whenever there is an indication of impairment).

Indefinite does not mean infinite. It means the entity cannot determine a period beyond which the asset will not generate benefits. A brand with strong, consistently growing consumer recognition and no regulatory or competitive threat on the horizon may genuinely have an indefinite life. But this assessment is reviewed at each reporting date. An asset that was indefinite-life can become finite-life if circumstances change, triggering prospective amortisation from that date.

Acquired goodwill under IFRS 3 is treated as an indefinite-life intangible for impairment testing purposes, though it is accounted for under IFRS 3 rather than IAS 38. The IASB's reasoning is the same: the period over which goodwill contributes to cash flows cannot be reliably estimated.

---

Derecognition

An intangible asset is derecognised on disposal or when no future economic benefits are expected from its use or disposal. The gain or loss on derecognition is the net disposal proceeds less the carrying amount. Gains are recognised in profit or loss, not as revenue. The mechanics mirror IAS 16.

---

Ind AS 38 vs IAS 38: Key Differences

The cloud computing point is practically relevant for Indian IT services companies and their customers. Costs incurred to configure or customise a cloud-based SaaS solution where the supplier hosts the software are generally expensed, not capitalised, because the customer does not control the software asset. Implementation costs that produce a separate, identifiable asset (such as data migration, integration code that the entity controls) may qualify for capitalisation. This is an area where practice continues to evolve.

---

What Big 4 Auditors Focus On

Research vs development switchover documentation. The most common IAS 38 error is premature capitalisation: treating expenditure as development when all six criteria are not yet demonstrably met. Auditors test the specific documentation of when each criterion was satisfied, who made the determination, and what evidence existed at that date. A pharmaceutical company that begins capitalising development costs from the start of a clinical trial when technical feasibility has not yet been demonstrated is capitalising prematurely.

Prohibition compliance for internally generated assets. Auditors check whether any expenditure has been capitalised that falls within the explicit IAS 38 prohibitions: training costs, advertising, brand-building, start-up costs. In fast-growing Indian consumer and fintech companies, the line between product development (potentially capitalisable) and marketing (always expensed) requires careful review.

Indefinite life assessment robustness. For assets classified as indefinite useful life, auditors test whether the assessment is supported by evidence: the absence of legal, regulatory, or competitive factors that would limit the asset's life. An acquired trademark classified as indefinite life in a rapidly evolving consumer market requires more evidence than a perpetual licence in a regulated industry.

Amortisation method and useful life review. Auditors verify that the amortisation method and useful life are reviewed annually, that changes in useful life are applied prospectively as changes in accounting estimate, and that the method reflects actual economic benefit consumption. A straight-line amortisation over 20 years for a technology patent in a fast-moving sector may not reflect economic reality.

IFRS 3 purchase price allocation intangibles. In post-acquisition audit work, auditors test whether all identifiable intangible assets have been captured in the PPA, valued at fair value, and classified with appropriate useful lives. Understating intangibles and overstating goodwill understates amortisation and potentially overstates future earnings.

---

Dip IFRS Exam Angle

IAS 38 questions appear in Dip IFRS both as classification exercises (expense or capitalise?) and as calculation questions (measure the asset and the amortisation).

Most tested areas:

Research vs development: given a timeline of activities, identify the point at which research transitions to development and the six criteria are first demonstrably met. All expenditure before that point is expensed; subsequent expenditure is capitalised.

Prohibited items: given a list of internally generated costs, identify which are prohibited from capitalisation. Brands, customer lists, training, advertising, and goodwill are always expensed.

Finite vs indefinite life: given an asset description, determine whether useful life is finite (amortise) or indefinite (annual impairment test only). Know what "indefinite" means: no foreseeable limit, not infinite.

Separately acquired vs internally generated: separately acquired intangibles almost always qualify for recognition; internally generated ones face the full research/development hurdle.

Common traps:

Capitalising research expenditure. Never. Even if the research ultimately leads to a successful product, past research expenditure is not retroactively capitalised.

Capitalising advertising and promotional costs. These are always expensed, regardless of whether future economic benefits are demonstrable.

Confusing indefinite life with zero amortisation and no impairment. Indefinite-life assets are not amortised but are tested for impairment annually. They are not ignored.

Assuming all development expenditure is automatically capitalised once the development phase begins. All six criteria must be met for each period of expenditure. Expenditure in a development period where one criterion (say, technical feasibility) is temporarily in doubt is still expensed for that period.

---

FAQ

Can previously expensed research costs be capitalised later when criteria are met?

No. IAS 38 is explicit: once recognised as an expense, expenditure on an intangible item cannot be subsequently recognised as part of the cost of an asset. The switch to capitalisation is prospective from the date all six criteria are first met.

Why are internally generated brands not recognised when acquired brands are?

An acquired brand has a purchase price that provides reliable evidence of cost. An internally generated brand's cost is inseparable from the general cost of running and marketing the business. You cannot reliably distinguish brand-building spend from general marketing, management, and distribution costs. Reliable measurement fails for internally generated brands; it succeeds for acquired ones.

What is the accounting treatment for a partially internally generated intangible?

The cost includes only expenditure from the date when all six development criteria are first met. Prior expenditure (research phase or development expenditure before the criteria are met) is expensed and stays expensed.

Can an entity choose not to capitalise development expenditure that meets the criteria?

No. IAS 38 requires capitalisation when all six criteria are met. It is not an option. Choosing to expense qualifying development costs is non-compliant. This is different from the treatment under some other GAAPs (including the old Indian GAAP) where development cost capitalisation was optional.

Is goodwill an intangible asset under IAS 38?

Goodwill is within the scope of IAS 38 conceptually, but acquired goodwill is accounted for under IFRS 3 rather than IAS 38. Internally generated goodwill is within scope but cannot be recognised because it is not identifiable. The IAS 38 framework applies to the amortisation of finite-life intangibles and the annual impairment testing of indefinite-life intangibles (which by analogy applies to acquired goodwill under IFRS 3/IAS 36).

Does the cloud computing configuration cost treatment differ between SaaS and on-premise software?

Yes. For on-premise software that the entity installs and controls, development phase costs meeting the IAS 38 criteria are capitalised. For cloud-based SaaS where the provider hosts and controls the software, configuration and customisation costs are generally expensed because the entity does not control the software asset. The distinction turns on control: does the entity control the resulting intangible, or does the service provider?

---

Enroll with Global Fin X

IAS 38 is tested consistently in Dip IFRS, both in isolation and in combination with IFRS 3 purchase price allocation scenarios. The research vs development distinction, the prohibited items list, and the finite vs indefinite useful life assessment are exam-critical areas. Our programme covers IAS 38 across two posts with in-depth lectures, worked examples, exam-style MCQs, and a dedicated LMS for working professionals.

Enroll Now: Dip IFRS Programme

Faculty profile: www.globalfinx.in/manikanta

---

This is Post 36 of the Global Fin X IFRS Series. Previous: IAS 40: Investment Property. Next: Post 37: IAS 38 R&D Costs, Software Capitalisation and Indian IT Sector.